HYQVIA

takeda canada inc🇨🇦 Health Canada

Approval Id: 21044817dc0da158
Drug Approval Canada Name: HYQVIA
Product Name: HYQVIA
Status: Marketed
Status Date: 2023-11-07
Original Market Date: 2023-11-07
Din: 02524406
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D
Ahfs: 80:04.00
Atc Original: J06BA01 IMMUNOGLOBULINS, NORMAL HUMAN, FOR EXTRAVASC. ADM
Atc Name: j 06 ba 01
Aig Number: 0263359001
Company Name: takeda canada inc
Company Address: 3800, 22 Adelaide Street West, Toronto, Ontario, Canada, M5H 4E3

HYALURONIDASE (HUMAN RECOMBINANT)

2400 UNIT / 15 ML

IMMUNOGLOBULIN (HUMAN)

30 G / 300 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

21044817dc0da158

Type

Standard